Drug ID: | NPD6559 |
Drug Name: | T-1095 |
Molecular Formula: | C26H28O11 |
Canonical SMILES: | COC(=O)OC[C@H]1O[C@@H](Oc2cc(C)cc(c2C(=O)CCc2ccc3c(c2)cco3)O)[C@@H]([C@H]([C@@H]1O)O)O |
Standard InCHI: | InChI=1S/C26H28O11/c1-13-9-17(28)21(16(27)5-3-14-4-6-18-15(11-14)7-8-34-18)19(10-13)36-25-24(31)23(30)22(29)20(37-25)12-35-26(32)33-2/h4,6-11,20,22-25,28-31H,3,5,12H2,1-2H3/t20-,22-,23+,24-,25-/m1/s1 |
Standard InCHIKey: | BXNCIERBDJYIQT-PRDVQWLOSA-N |
Max Developmental Stage: | Discontinued |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB010794 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 516.16 |
ALogP | -1.3239 |
MLogP | 3.11 |
XLogP | 2.811 |
HDA | 8 |
HBD | 4 |
Rotatable Bonds | 16 |
TPSA | 165.12 |
RO5 Violation | 0 |